Serum EV-MDM2 may be the first biomarker for retroperitoneal liposarcoma (RLS) recurrence. EV-MDM2 levels drop post-surgery but rise with recurrence. This can guide early detection and treatment decisions.
Get health updates from Dr Harsh Shah on WhatsApp
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.